Risk of infections with biological agents.
Gastroenterol Clin North Am
; 43(3): 509-24, 2014 Sep.
Article
em En
| MEDLINE
| ID: mdl-25110256
ABSTRACT
An increasing proportion of patients with inflammatory bowel disease (IBD) are treated with biological medications. The risk of infectious complications remains a significant concern in patients treated with biologics. Treatment with biological agents in IBD is generally safe, but there may be an increased risk of certain opportunistic infections. Some of the infectious risks are class specific, whereas others are a common concern for all biologics. A careful screening, surveillance, and immunization program, in accordance with available guidelines, is important to minimize any risk of infectious complications.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Infecções Bacterianas
/
Produtos Biológicos
/
Infecções Oportunistas
/
Viroses
/
Doenças Inflamatórias Intestinais
/
Fator de Necrose Tumoral alfa
/
Imunossupressores
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article